# Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

> **NCT00003129** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 75 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** valrubicin

## Key facts

- **NCT ID:** NCT00003129
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09-01
- **Primary completion:** 2002-11
- **Final completion:** 2009-05-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2023-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003129, "Chemotherapy in Treating Patients With Early-Stage Bladder Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00003129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*